Projets
Programmes Européens
TumAdoR - 602200 (Exploitation)/26075075
2013 - 2017 (48 mois)
Requérant : Pedro Romero
Development of very promising humanized therapeutic mAbs efficiently neutralizing a novel immunosuppressive pathway involved in a wide range of cancers
Improve-602705 (Exploitation) r.26075028
2014 - 2018 (48 mois)
Requérant : Pedro Romero
Improving Prostate Cancer Outcome with Vectored Vaccines
322875-Antivessel-T- Cells /exploitation
2013 - 2018 (60 mois)
Requérant : Natasa Jovanovic, Philippe Germanier
Development of Vascular-Disrupting Lymphocyte Therapy for Tumours
